Second-line pharmacotherapy intensification after metformin monotherapy in type 2 diabetes: a nationwide register study from Finland during 2011–2022
Second-line treatment intensification patterns over time paralleled the changes in the reimbursement system. Thus, our findings suggest that the reimbursement policy may influence the use of ADMs in Finland.
Authors
- Helena Kastarinen (ORCID: https://orcid.org/0009-0008-6985-1598)
- Hanna Rättö (ORCID: https://orcid.org/0000-0002-5122-1175)
- Pia Pajunen (ORCID: https://orcid.org/0009-0002-1193-2578)
- Terhi Kurko (ORCID: https://orcid.org/0009-0004-3672-6628)
Institutions
- Social Insurance Institution (FI)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s12913-024-11325-0
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36